Press release - 14/01/2009 Looking for the Achilles’ heel of parasites Researchers have identified a hormone that controls whether nematode larvae turn into parasites or not.https://www.gesundheitsindustrie-bw.de/en/article/press-release/looking-for-the-achilles-heel-of-parasites
Press release - 14/01/2009 IND Approval for CureVac CureVac Receives IND Approval from the FDA to start its Phase I/IIa mRNA Vaccine Clinical Trial in Prostate Cancer. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ind-approval-for-curevac
Article - 14/01/2009 GEHR Kunststoffwerk – new applications for bioplastics GEHR Kunststoffwerk GmbH & Co. KG, founded in 1932 and owned by the Gehr family ever since, is one of the world’s leading manufacturers of semi-finished thermoplastics. The company’s headquarters are in Mannheim.https://www.biooekonomie-bw.de/en/articles/news/gehr-kunststoffwerk-new-applications-for-bioplastics
Press release - 14/01/2009 Hunters of lost treasures On 1st December 2008 Prof. Dr. Karl Schmid the first person to hold the F.W. Schnell Foundations endowed professorship for crop biodiversity and breeding informatics started the ball rolling on a unique European-wide project. Schmid and his colleagues are searching gigantic databases in which genetic analyses and plant descriptions are stored for hidden treasures. https://www.biooekonomie-bw.de/en/articles/pm/hunters-of-lost-treasures
Press release - 14/01/2009 Hunters of lost treasures On 1st December 2008 Prof. Dr. Karl Schmid the first person to hold the F.W. Schnell Foundations endowed professorship for crop biodiversity and breeding informatics started the ball rolling on a unique European-wide project. Schmid and his colleagues are searching gigantic databases in which genetic analyses and plant descriptions are stored for hidden treasures. https://www.gesundheitsindustrie-bw.de/en/article/press-release/hunters-of-lost-treasures
Dossier - 14/01/2009 Biopharmaceuticals continue their triumphant success The first genetically engineered drug entered the market a little over 25 years ago. Since then more than 100 others have been launched. Many of these biopharmaceuticals have an outstanding effect thus revolutionising the therapeutic options available in many medical sectors. Biopharmaceuticals also have a huge economic potential. The huge potential of these innovative drugs and their importance for Germanys pharmaceutical industry is reflected…https://www.gesundheitsindustrie-bw.de/en/article/dossier/biopharmaceuticals-continue-their-triumphant-success
Press release - 11/01/2009 What have sunscreens got to do with hormones? Most people are well aware that sunbathing can have dangerous consequences. In Switzerland the debate concerning the undesirable side effects of sunscreens has been temporarily put on hold but will most likely start up again with the onset of the winter season. Daniel R. Dietrich chair of the Department of Toxicology at the University of Constance gives us more details in the following interview.https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-have-sunscreens-got-to-do-with-hormones
Press release - 11/01/2009 Killing cancer cells with only limited side effects A group of clinical researchers at the University Hospital in Ulm has discovered new ways to specifically kill cancer cells with radioactive irradiation while preventing healthy organs from being affected. The researchers have also discovered that this method breaks the chemoresistance of cancer cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/killing-cancer-cells-with-only-limited-side-effects
Press release - 11/01/2009 Merckle’s empire collapse leads to sale of ratiopharm It was clear that something was amiss in 2008, and now things are clearer: The Ulm-based generics producer ratiopharm is to be sold in order to save the Merckle empire that has run into difficulties in the global financial crisis. Numerous sources report that the pharmaceutical company will not be sold before 2010 due to the current unfavourable market situation. It is not known whether the Merckle group will have to part with other companies in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/merckle-s-empire-collapse-leads-to-sale-of-ratiopharm
Press release - 10/01/2009 Supporting equal opportunities for women at universities in Baden-Württemberg The Baden-Württemberg government now brings together information regarding equal opportunities as well as “Girls and Technology” projects at the state’s universities on the www.scientifica.de Internet portal. https://www.gesundheitsindustrie-bw.de/en/article/press-release/supporting-equal-opportunities-for-women-at-universities-in-baden-wuerttemberg
Article - 10/01/2009 Julia Kirchheiner searches for drugs for individuals Drugs for individuals rather than diseases - thats what Julia Kirchheiner from the University of Ulm is striving for. The 37-year-old is one of only a handful German experts working in pharmacogenetics research a field of research that investigates the genetic causes of individual differences in peoples response to drugs. https://www.gesundheitsindustrie-bw.de/en/article/news/julia-kirchheiner-searches-for-drugs-for-individuals
Article - 09/01/2009 Kay Diederichs – important insights in the fight against bacterial antibiotics resistance Bacteria will always find ways to defend themselves against substances such as antibiotics, thus inhibiting their effect. Many bacteria have pump systems that they use to actively remove antibiotic drugs from the cell. Prof. Kay Diederichs at the University of Constance is working on the elucidation of these mechanisms in order to produce useful information for the development of bacterial pump inhibitors. https://www.gesundheitsindustrie-bw.de/en/article/news/kay-diederichs-important-insights-in-the-fight-against-bacterial-antibiotics-resistance
Press release - 09/01/2009 Richter to succeed Siegenführ Dr. Michael Richter is the new German BioValley/Freiburg Bioregion coordinator. He succeeds Dr. Thea Siegenführ who has shaped and skilfully organised the biotechnology landscape on the Upper Rhine for the last 16 years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/richter-to-succeed-siegenfuehr
Press release - 08/01/2009 ILM – Bioactive interfaces It is particularly important to consider the biocompatibility of material interfaces. For example, implant materials with a surface composition that favours cell growth have a decisive advantage. However there are other cases where biophobic material characteristics might be more suitable. For example, specifically modifying the surface of surgical metals might prevent pathogens from attaching and could also make the cleaning and deactivation of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-bioactive-interfaces
Press release - 08/01/2009 ILM – Microscopic analyses Among the ILM’s established methods are fluorescence in-situ hybridisation, multicolour fluorescence in-situ hybridisation and laser microdissection. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-microscopic-analyses
Press release - 08/01/2009 ILM – Light scattering of cylindrical structures Many biological tissues contain cylindrical microstructures, including teeth, muscles and skin. Therefore, the detailed understanding of light propagation in these structures is of great importance for biomedical optics. The transport theory is often used for the numerical calculation of light propagation in biological tissue. The ILM uses the Monte Carlo method to make these calculations.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-light-scattering-of-cylindrical-structures
Press release - 08/01/2009 ILM - Microscopy A collaborative project funded by the Landesstiftung Baden-Württemberg foundation, investigated the extent to which spectrally resolved Raman microscopy is able to represent specific enzymes in living cells without the use of markers.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-microscopy
Press release - 08/01/2009 ILM – Organisational structure and competences In analogy to its thematic development, the ILM organisational structure previously consisted of (1) Medicine, (2) Metrology and (3) Dental Technology (DTZ) divisions. The respective areas were each managed by one individual. In line with thematic requirements, different core competences have developed over time in these areas: microscopy and biology in medicine, photothermics in metrology, tissue optics and device development in dental…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-organisational-structure-and-competences
Press release - 08/01/2009 ILM – Lasers and laser safety It goes without saying that one of the ILM’s core competences is the use of a broad range of different laser systems. In the area of technical laser applications, this involves the development of innovative lasers, the modification of commercially available lasers as well as application tests for medical laser systems. A broad range of instruments is required to determine laser parameters, in particular for the determination of the laser beam…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-lasers-and-laser-safety
Press release - 08/01/2009 ILM – Alternative models to replace animal experiments Since the beginning of the last century, fertilised chicken eggs have been an established model system and are nowadays often used as an alternative to animal experiments. The test model involves the use of the outer, strongly vascularised amnion (the so-called chorioallantoic membrane, CAM) which surrounds the embryo and is used for gas exchange during embryonic development.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-alternative-models-to-replace-animal-experiments
Press release - 08/01/2009 ILM – Laser Therapy Centre The Laser Therapy Centre (LTZ) possesses numerous medical laser systems of different wavelengths and pulse structures. In cooperation with medical laser device manufacturers, the ILM is actively involved in the development of new lasers and laser applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-laser-therapy-centre-1
Press release - 08/01/2009 ILM – In-line determination of roughness in paper production An important parameter for the printability of paper is its microstructure and roughness. Previous approaches used to identify these parameters were limited to individual quality controls in the laboratory; no technology has so far been available for process-integrated sensoring. The ILM has taken on the task of solving this issue.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-in-line-determination-of-roughness-in-paper-production
Press release - 08/01/2009 ILM – Scattered light measurement Goniometers can be used to measure the angle-dependent characteristics of light beams and surface scattering. This enables conclusions to be drawn on the structure of a surface.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-scattered-light-measurement
Press release - 08/01/2009 ILM – Radiobiology and biological dosimetry II Lasers, in particular holmium-Yag and dye lasers are being used to an increasing extent in urology to destroy kidney stones. In order to obtain a better understanding of the mechanism of action, detailed investigations were carried out in cooperation with the Laser Centre in Munich.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-radiobiology-and-biological-dosimetry-ii
Press release - 08/01/2009 ILM - FLIM/SLIM to monitor protein interactions In collaboration with the Department of Neurology at the University of Ulm, the ILM is working on a project called OPTIMA (Optical methods for the in vivo monitoring of protein interactions using Alzheimer’s disease as example), which is funded by the BMWi. The project is aimed at developing optical methods for the in vivo monitoring of complex intracellular protein interactions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-flim-slim-to-monitor-protein-interactions